These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23354063)

  • 1. From noncovalent to covalent bonds: a paradigm shift in target protein identification.
    Park J; Koh M; Park SB
    Mol Biosyst; 2013 Apr; 9(4):544-50. PubMed ID: 23354063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target identification for small bioactive molecules: finding the needle in the haystack.
    Ziegler S; Pries V; Hedberg C; Waldmann H
    Angew Chem Int Ed Engl; 2013 Mar; 52(10):2744-92. PubMed ID: 23418026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tools and methodologies capable of isolating and identifying a target molecule for a bioactive compound.
    Sakamoto S; Hatakeyama M; Ito T; Handa H
    Bioorg Med Chem; 2012 Mar; 20(6):1990-2001. PubMed ID: 22264760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in identifying protein targets in drug discovery.
    Ha J; Park H; Park J; Park SB
    Cell Chem Biol; 2021 Mar; 28(3):394-423. PubMed ID: 33357463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly.
    Erlanson DA; Hansen SK
    Curr Opin Chem Biol; 2004 Aug; 8(4):399-406. PubMed ID: 15288250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical target isolation for novices: affinity-based strategies.
    Sato S; Murata A; Shirakawa T; Uesugi M
    Chem Biol; 2010 Jun; 17(6):616-23. PubMed ID: 20609411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of a Novel Affinity Labeling Method for Target Identification of Bioactive Small Molecules].
    Yamaguchi T
    Yakugaku Zasshi; 2019; 139(12):1513-1521. PubMed ID: 31787638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-based protein profiling for natural product target discovery.
    Krysiak J; Breinbauer R
    Top Curr Chem; 2012; 324():43-84. PubMed ID: 22025071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of mass spectrometry in early stages of target based drug discovery.
    Deng G; Sanyal G
    J Pharm Biomed Anal; 2006 Feb; 40(3):528-38. PubMed ID: 16256286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural biology and drug discovery for protein-protein interactions.
    Jubb H; Higueruelo AP; Winter A; Blundell TL
    Trends Pharmacol Sci; 2012 May; 33(5):241-8. PubMed ID: 22503442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide aptamers as guides for small-molecule drug discovery.
    Baines IC; Colas P
    Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the cellular targets of bioactive small organic molecules using affinity reagents.
    Leslie BJ; Hergenrother PJ
    Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.